Ozempic vs Wegovy: What's the Difference?

Quick Comparison

How They're the Same

Ozempic and Wegovy have more in common than not:

• Same active ingredient: Both contain semaglutide, a GLP-1 receptor agonist
• Same manufacturer: Both are made by Novo Nordisk
• Same mechanism: Semaglutide mimics GLP-1, a hormone that helps regulate blood sugar, slows digestion, and reduces appetite
• Same injection schedule: Both are injected once weekly, on the same day each week
• Same common side effects: Nausea, diarrhea, constipation, stomach pain, fatigue
• Same dose ramp-up: Both start at 0.25 mg and increase gradually

If you've been on one, your body is already familiar with the drug. The differences come down to dose and FDA labeling.

How They're Different

FDA approval

This is the biggest difference. Ozempic is FDA-approved for type 2 diabetes. Wegovy is FDA-approved for weight management — specifically for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition like high blood pressure or high cholesterol.

Some doctors prescribe Ozempic off-label for weight loss, but that's not its approved use. Insurance may not cover it for that purpose.

Dosing amounts

Both start at 0.25 mg weekly. But Wegovy goes higher:

Wegovy's 2.4 mg maintenance dose is the highest approved semaglutide dose. This higher dose was studied and approved specifically for weight management.

Pen appearance

The pens look different, which helps avoid mix-ups:

• Ozempic: Red cap, white body. Available in 0.25/0.5 mg and 1 mg pen sizes, plus a 2 mg pen.
• Wegovy: Blue cap, white body. Each pen delivers one dose strength (separate pens for each step).

Insurance coverage

Coverage often depends on what you're being treated for:

• Ozempic is more likely to be covered when prescribed for type 2 diabetes
• Wegovy may be covered for weight management, but many plans still exclude weight loss medications
• Using Ozempic off-label for weight loss often means paying out of pocket

Check your plan's formulary to see which medication is covered and at what tier.

Clinical Trial Results

Wegovy: STEP trials

Wegovy's FDA approval for weight management is based on the STEP trial program. In the STEP 1 trial, participants taking semaglutide 2.4 mg lost an average of ~15% of their body weight over 68 weeks, compared to ~2.4% in the placebo group. About 86% of participants lost at least 5% of their body weight.

The STEP 2 trial looked at people with type 2 diabetes. In that group, average weight loss was ~10% over 68 weeks on the 2.4 mg dose. Blood sugar also improved.

The STEP 4 trial showed that people who stayed on semaglutide 2.4 mg continued to lose weight or maintain their loss, while those switched to placebo regained most of the weight.

Ozempic: SUSTAIN and PIONEER trials

Ozempic's approval is based on the SUSTAIN trial program (injectable) and PIONEER program (oral). The SUSTAIN trials focused on blood sugar control in type 2 diabetes. Key results:

• A1C reduction: Participants on semaglutide 1 mg saw A1C reductions of 1.4–1.8 percentage points on average, depending on the trial
• Weight loss: People in the SUSTAIN trials lost ~4–6% of body weight on average at the 1 mg dose. At 2 mg, weight loss was somewhat higher.

These numbers are lower than Wegovy's because the SUSTAIN trials tested lower doses in people with diabetes, not the 2.4 mg dose for weight management.

Important: These are clinical trial averages. Individual results vary. Your weight loss depends on dose, diet, activity, and how your body responds.

Cost Comparison

Wegovy's list price is higher, but savings programs can reduce the gap. If you have commercial insurance that covers either drug, you may qualify for a manufacturer savings card. Without insurance, both are expensive.

For detailed savings options across all GLP-1 medications, see our GLP-1 savings cards guide.

Who Should Consider Each

Neither medication is "better" across the board. They serve different purposes.

Ozempic is FDA-approved for type 2 diabetes. It may be appropriate if:

• You have type 2 diabetes and need blood sugar control
• Your insurance covers Ozempic for diabetes
• Your prescriber recommends semaglutide as part of your diabetes treatment

Wegovy is FDA-approved for weight management. It may be appropriate if:

• You have obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a weight-related condition
• Your primary goal is weight loss
• Your insurance covers Wegovy for weight management
• You need the higher 2.4 mg semaglutide dose

Some people with type 2 diabetes who also need weight management may be candidates for Wegovy, since the STEP 2 trial showed benefits for both blood sugar and weight. Talk to your prescriber about which indication fits your situation.

Switching Between Ozempic and Wegovy

Switching is common, especially during shortages or when insurance coverage changes. Since both contain semaglutide, your body is already adjusted to the drug. But the dose differences matter.

Ozempic to Wegovy: If you're stable on Ozempic, your prescriber may transition you to the closest Wegovy dose and then titrate up if appropriate. Someone on Ozempic 1 mg might start Wegovy at 1.0 mg and increase from there.

Wegovy to Ozempic: If you're switching from Wegovy to Ozempic, the highest Ozempic dose is 2 mg. If you were on Wegovy 2.4 mg, you'll move to a lower semaglutide dose.

Do not switch on your own. Your prescriber needs to determine the right starting dose and schedule for the new medication. Even though the drug is the same, the dose change can affect side effects and how well the medication works for you.

Dosing Schedules

Important: The schedules below are general summaries of FDA-approved titration protocols, not instructions for your treatment. Your prescriber determines your dose and timing. Do not adjust your dose without consulting them.

Ozempic (weekly, per FDA label)

• Week 1–4: 0.25 mg once weekly
• Week 5–8: 0.5 mg once weekly
• Week 9+: May increase to 1 mg, then to 2 mg based on response

Wegovy (weekly, per FDA label)

• Month 1: 0.25 mg once weekly
• Month 2: 0.5 mg once weekly
• Month 3: 1.0 mg once weekly
• Month 4: 1.7 mg once weekly
• Month 5+: 2.4 mg once weekly (maintenance)

Both use a gradual ramp-up to reduce gastrointestinal side effects. This reflects the standard FDA-approved titration schedule. Your prescriber determines your actual dose.

Side Effects

Since they're the same drug, side effects are the same:

• Nausea (most common)
• Diarrhea or constipation
• Decreased appetite
• Stomach pain
• Fatigue

At higher doses, side effects tend to be more noticeable. Wegovy's 2.4 mg dose may cause more nausea than Ozempic's 1 mg dose for some people. Side effects usually hit hardest when you start and after each dose increase. They tend to settle down after a few weeks.

Rare but serious side effects for both medications include pancreatitis, gallbladder disease, and thyroid tumors (seen in animal studies). Contact your doctor immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction.

For help managing common side effects, see Nausea Triggers and Management.

FAQ

Is Ozempic the same as Wegovy?

Both contain the same active drug (semaglutide) but are approved for different uses. Ozempic is approved for type 2 diabetes, while Wegovy is approved for weight management. Wegovy also goes up to a higher dose (2.4 mg vs 2 mg).

Can I take Ozempic instead of Wegovy?

Some providers prescribe Ozempic off-label for weight loss. However, Wegovy is specifically FDA-approved for weight management and reaches a higher dose (2.4 mg vs 2 mg). Insurance coverage differs — Ozempic may not be covered if prescribed for weight loss rather than diabetes. Talk to your prescriber about which option fits your situation and coverage.

Why does Wegovy have a higher dose?

Wegovy goes up to 2.4 mg because that dose was specifically studied and approved for weight management in the STEP clinical trial program. Ozempic was studied and approved for type 2 diabetes at doses up to 2 mg. The same drug can have different optimal doses depending on the condition being treated.

Does insurance cover both?

It depends on your plan and what you're being treated for. Ozempic is more likely to be covered when prescribed for type 2 diabetes. Wegovy may be covered for weight management on some plans but not others. Many insurance plans still exclude weight loss medications. Check your formulary or call your insurance provider to confirm coverage for each.

Which is more expensive, Ozempic or Wegovy?

Wegovy has a higher list price (~$1,349/month vs ~$935/month). However, your actual cost depends on insurance coverage and savings card eligibility. With manufacturer savings programs, both may be available for as low as $25/month with qualifying commercial insurance.

Products That Can Help

Starting semaglutide? These products may help:

• Weekly pill organizer — Track your injection day each week
• Smart scale — Monitor weight loss progress
• Protein powder — Meet protein goals during weight loss
• Sharps container — Safe disposal for injection pens

GLPSpot may earn from qualifying purchases.

Bottom Line

Ozempic and Wegovy are the same drug at different doses with different FDA approvals. Ozempic is approved for type 2 diabetes at doses up to 2 mg. Wegovy is approved for weight management at doses up to 2.4 mg.

The right choice depends on your health situation, your insurance, and what your prescriber recommends. If you have type 2 diabetes, Ozempic may be the more natural fit. If your primary goal is weight management and you meet the BMI criteria, Wegovy is the FDA-approved option.

Work with your healthcare provider to determine which medication is right for you. Individual results and experiences vary.

See also

• Ozempic vs Rybelsus
• Wegovy vs Saxenda